Answers are grounded in this paper and cite their sources.
Here, we present a search-based strategy for disease detection and classification, which detects diseased samples via their outlier novelty versus a database of samples from healthy subjects and then compares them to databases of samples from patients. This approach enables the identification of microbiome states associated with disease even in the presence of different cohorts, multiple sequencing platforms, or significant contamination.
No takes yet. Share an insight, caveat, or question.
Su et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: